Davis Polk advised J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as joint book-running managers in connection with the $54 million initial public offering of 5,400,000 shares of common stock of NanoString Technologies, Inc. at $10.00 per share. The common stock is listed on the Nasdaq Global Market under the symbol “NSTG.”
Based in Seattle, WA, NanoString develops, manufactures and sells robust, intuitive products that unlock scientifically valuable and clinically actionable genomic information from minute amounts of tissue.
The Menlo Park-based Davis Polk corporate team included partner Alan F. Denenberg and associate Paul Weitzel. Partner Frank J. Azzopardi and associate Bruce Rose-Innes provided intellectual property advice. The tax team included partner Rachel D. Kleinberg and associate Catherine Paskoff Chang. Counsel Cynthia Akard, Marcie A. Goldstein and Catherine L. Martin provided employee benefit, FINRA and ‘40 Act advice, respectively.
